Wed, Aug 27, 2014, 1:00 PM EDT - U.S. Markets close in 3 hrs.

Recent

% | $
Quotes you view appear here for quick access.

Inovio Pharmaceuticals, Inc. Message Board

myung0905 5 posts  |  Last Activity: Jun 11, 2014 11:01 AM Member since: Feb 16, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • I have several stock screeners that I used to check everyday. I found this suspicious data yesterday about SPDR S&P Biotech ETF. i didn't manipulate any data at all. Can anybody tell what is going on?
    SPDR S&P Biotech ETF 1,251,262 (share) Mar 31, 2014 (yahoo)
    SPDR S&P Biotech ETF 1,029,655 (share) 6,930 (change) 06/09/2014
    SPDR S&P Biotech ETF 1,022,725 (shares) 1,022,725(change)06/06/2014

    Sentiment: Hold

  • myung0905 by myung0905 Jun 11, 2014 10:29 AM Flag

    I have several stock screeners that I used to check everyday. I found this suspicious data yesterday about SPDR S&P Biotech ETF. i didn't manipulate any data at all. Can anybody tell what is going on?
    SPDR S&P Biotech ETF 1,251,262 (share) Mar 31, 2014 (yahoo)
    SPDR S&P Biotech ETF 1,029,655 (share) 6,930 (change) 06/09/2014
    SPDR S&P Biotech ETF 1,022,725 (shares) 1,022,725(change)06/06/2014

    Sentiment: Hold

  • SPDR S&P Biotech ETF 1,251,262 (share) Mar 31, 2014
    SPDR S&P Biotech ETF 1,029,655 (share) 6,930 (change) 06/09/2014
    SPDR S&P Biotech ETF 1,022,725 (shares) 1,022,725(change)06/06/2014

  • myung0905 by myung0905 Jun 10, 2014 6:11 PM Flag

    J. Kim has been working with immunology for over 20 years.
    I cited several comments we have to read carefully. These clinical trials are real situations. And imagine what he felt when he said about the treatments . He cannot play with the patients who have suffered with cancer.

    J. Kim said,
    -Some of these are among the largest and smartest biotech investors in the world. These buy-side investors obviously want to have exposure to the stock prior to our forthcoming Phase II data.Our goal is to have the best and most extensive pipeline of active cancer immunotherapies with the potential to seek out and destroy cancer cells," said Dr. Kim. (Jun. 9, 2014 10:41 AM ET )

    -Today's therapy for oropharyngeal (head & neck) cancer is a combination of chemotherapy, radiation and surgical resection. The treatments have many potential side effects, including damage to the throat, which can hinder the ability to speak and swallow. (June 10, 2014)

  • Maybe he had an American dream when he went to ivy league school as a typical Asian boy and I think he almost makes his dream come true. That is the reason why he wants rs in INO. Now INO is a golden stock.

INO
10.74+0.42(+4.07%)1:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.